Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥18.5bn2025-01-01 → 2025-06-30Cons.Net sales
Revenue¥29.3bn2024-01-01 → 2024-12-31Cons.Net sales (5-year summary)
Revenue¥14.7bn2024-01-01 → 2024-06-30Cons.Net sales
Operating income¥1.5bn2025-01-01 → 2025-06-30Cons.Operating income
Operating income¥2.3bn2024-01-01 → 2024-06-30Cons.Operating income
Ordinary income¥1.6bn2025-01-01 → 2025-06-30Cons.Ordinary income
Ordinary income¥4.1bn2024-01-01 → 2024-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.2bn2024-01-01 → 2024-06-30Cons.Ordinary income
Profit before tax¥1.8bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Profit before tax¥3.2bn2024-01-01 → 2024-06-30Cons.Income before income taxes
Net income (owners)¥647m2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.0bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income¥647m2025-01-01 → 2025-06-30Cons.Profit loss
Net income¥2.1bn2024-01-01 → 2024-06-30Cons.Profit loss
Total assets¥47.4bnat 2025-06-30Cons.Assets
Total assets¥45.2bnat 2024-12-31Cons.Assets
Total assets¥42.2bnat 2024-06-30Cons.Total assets (5-year summary)
Total liabilities¥29.4bnat 2025-06-30Cons.Liabilities
Total liabilities¥25.0bnat 2024-12-31Cons.Liabilities
Net assets / equity¥18.1bnat 2025-06-30Cons.Net assets
Net assets / equity¥20.2bnat 2024-12-31Cons.Net assets
Net assets / equity¥19.5bnat 2024-06-30Cons.Net assets (5-year summary)
Cash and deposits¥13.5bnat 2025-06-30Cons.Cash and deposits
Cash and deposits¥19.0bnat 2024-12-31Cons.Cash and deposits
Cash & equivalents¥13.5bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥19.0bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥20.9bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥15.4bnat 2023-12-31vCons.Cash and cash equivalents
Operating cash flow¥1.9bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.5bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥6.3bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.7bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8.2bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.1bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥11.9bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥11.1bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥20.052025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥86.172024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥61.92024-01-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥19.952025-01-01 → 2025-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥85.622024-01-01 → 2024-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥61.52024-01-01 → 2024-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio38.1%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.7%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio46.1%at 2024-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥1m
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥1m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥2.9bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥4.5bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥4.5bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentsegment profit2025-01-01 → 2025-06-30−¥51m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue2025-01-01 → 2025-06-30¥589m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue external2025-01-01 → 2025-06-30¥589m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentsegment profit2025-01-01 → 2025-06-30−¥349m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥13.4bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥13.4bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-06-30¥18.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-06-30¥18.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-01-01 → 2025-06-30¥1m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-06-30¥4.4bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥2m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥2m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥2.2bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥3.6bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥3.6bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentsegment profit2024-01-01 → 2024-06-30¥43m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue2024-01-01 → 2024-06-30¥239m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue external2024-01-01 → 2024-06-30¥239m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentsegment profit2024-01-01 → 2024-06-30−¥132m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥10.9bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥10.9bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥2m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥14.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥14.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-01-01 → 2024-06-30¥2m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30¥4.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 534
ItemContextValueUnit
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1863
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember3295000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1023
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember2143000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0665
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember2013000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0625
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember1944000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0604
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember1131000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0351
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember1094000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0340
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember804000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0250
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember694000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0216
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember441000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0137
Number of shares heldCurrentQuarterInstant19566000
Shareholding ratioCurrentQuarterInstant0.6074
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember523300
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember321945
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember32194500
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember20800
Number of shares issued shares voting rightsCurrentQuarterInstant32738600
Number of voting rights issued shares voting rightsCurrentQuarterInstant321945
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member523300
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member523300
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0160
Number of shares held in own name treasury shares etcCurrentQuarterInstant523300
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant523300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0160
Cash and depositsPrior1YearInstant18996000000JPY
Cash and depositsCurrentQuarterInstant13524000000JPY
Notes and accounts receivable tradePrior1YearInstant2856000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant2792000000JPY
Merchandise and finished goodsPrior1YearInstant255000000JPY
Merchandise and finished goodsCurrentQuarterInstant291000000JPY
Work in processPrior1YearInstant17000000JPY
Work in processCurrentQuarterInstant40000000JPY
Accounts receivable otherPrior1YearInstant2872000000JPY
Accounts receivable otherCurrentQuarterInstant2597000000JPY
Prepaid expensesPrior1YearInstant364000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identityconsolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass